SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2022 Financial Results
14.11.2022 - – Cash Position of $21.3 Million as of September 30, 2022 – – Hosting Phase 3 REGAL Study Update Webcast Today at 8:30 a.m. ET – NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) - SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or ...
United States Hong Kong Raquel Cona Michaela Fawcett Angelos Stergiou Dragan Cicic Katherine Bach Kalin
Source: wallstreet-online.de